Is APGE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for APGE. It does not provide personalized investment advice.

APGE (Apogee Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Apogee Therapeutics, Inc. Common Stock (APGE) is a publicly traded Healthcare sector company. As of July 11, 2026, APGE trades at $133.65 with a market cap of $10.04B and a P/E ratio of -31.66. APGE moved +0.06% today. Year to date, APGE is +77.07%; over the trailing twelve months it is +246.51%. Its 52-week range spans $26.20 to $133.87. Analyst consensus is neutral with an average price target of $127.95. Rallies surfaces APGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are APGE's key financials?

APGE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. APGE recently traded at $133.65. Market cap is $10.04B. P/E ratio is -31.66. Revenue is $0.

APGE Key Metrics

Key financial metrics for APGE
Metric	Value
Price	$133.65
Market Cap	$10.04B
P/E Ratio	-31.66
EPS	$-4.22
Dividend Yield	0.00%
52-Week High	$133.87
52-Week Low	$26.20
Volume	659.08K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-255.84M
Gross Margin	0.00%

APGE Analyst Consensus

16 analysts cover APGE: 0 strong buy, 4 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $127.95.

Common questions about APGE

What are APGE's key financials?: APGE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. APGE recently traded at $133.65. Market cap is $10.04B. P/E ratio is -31.66. Revenue is $0.
Is APGE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for APGE. It does not provide personalized investment advice.